Balloon catheter aims to supercharge blood flow to heart and brain during arrest

NCT ID NCT05444049

Completed Disease control Sponsor: neurescue Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new device called NEURESCUE in 6 adults experiencing in-hospital cardiac arrest. The device is a balloon catheter inserted through the leg artery that inflates to redirect blood flow to the heart and brain. The goal was to see if it could be deployed quickly and safely alongside standard CPR.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: NEURESCUE device (a balloon catheter inserted into the femoral artery to redirect blood flow to the upper body)
What this could lead to: If successful, this device could help improve blood flow to vital organs during cardiac arrest, potentially increasing the chances of survival.
What could go wrong: This is a very small feasibility study with only 6 participants, so results may not apply broadly. The device is still experimental and may not improve outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC ARREST are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiac arrest cardiovascular disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIAC ARREST CARDIOPULMONARY ARREST CARDIOVASCULAR DISEASES

Contacts and locations

Locations

Long Beach Medical Center

Long Beach, California, 90806, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.